154 related articles for article (PubMed ID: 35371339)
21. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
Ma HW; Xi DY; Ma JZ; Guo M; Ma L; Ma DH; Li PW; Guo CA
Dis Markers; 2020; 2020():8140989. PubMed ID: 32051698
[TBL] [Abstract][Full Text] [Related]
22. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
Xiao G; Wang P; Zheng X; Liu D; Sun X
Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
[TBL] [Abstract][Full Text] [Related]
23. RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma.
Yan J; Wang ZH; Yan Y; Luo HN; Ren XY; Li N; Zheng GX; Hou J
Oncol Rep; 2020 Nov; 44(5):2080-2092. PubMed ID: 33000261
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of LEF1-AS1 regulating HUVEC cells by targeting miR-489-3p/S100A11 axis.
Zhang H; Wang W; Lin J; Qiao J; Wang X; Fang B; Chen C; Wang Y; Zhu G; Liu W
PeerJ; 2023; 11():e16128. PubMed ID: 37927791
[TBL] [Abstract][Full Text] [Related]
25. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
26. LEF1-AS1 accelerates tumorigenesis in glioma by sponging miR-489-3p to enhance HIGD1A.
Cheng Z; Wang G; Zhu W; Luo C; Guo Z
Cell Death Dis; 2020 Aug; 11(8):690. PubMed ID: 32826866
[TBL] [Abstract][Full Text] [Related]
27. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
28. LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis.
Feng B; Wang G; Liang X; Wu Z; Wang X; Dong Z; Guo Y; Shen S; Liang J; Guo W
J Cell Mol Med; 2020 Aug; 24(16):8962-8976. PubMed ID: 32583631
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
30. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
32. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LEF1-AS1 promotes osteogenic differentiation of dental pulp stem cells via sponging miR-24-3p.
Wu Y; Lian K; Sun C
Mol Cell Biochem; 2020 Dec; 475(1-2):161-169. PubMed ID: 32780211
[TBL] [Abstract][Full Text] [Related]
35. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
38. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis.
Zhang L; Zhou C; Qin Q; Liu Z; Li P
J Cell Biochem; 2019 Sep; 120(9):14670-14678. PubMed ID: 31016789
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
